voriconazole has been researched along with Carcinoma, Basal Cell in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arron, ST; Brownell, I; Cahoon, EK; Cowen, EW; D'Arcy, ME; Engels, EA; Hess, GP; Israni, AK; Pfeiffer, RM; Rivera, DR; Triplette, MA; Yanik, EL | 1 |
| Karagas, MR; Kuklinski, LF; Kwong, BY; Li, S; Weng, WK | 1 |
| Al-Sayegh, H; Bahrani, E; Bartenstein, D; Brahmbhatt, M; Chen, L; Coughlin, CC; Eichenfield, LF; Gerami, P; Haddock, E; Hawryluk, EB; Hook, K; Huang, JT; Humphrey, SR; Kruse, L; Lawley, L; London, WB; Mansour, D; Marghoob, A; Nguyen, J; Phung, TL; Pope, E; Raisanen, T; Robinson, S; Schmidt, B; Tran, G; Travis, K; Wolner, Z | 1 |
| Aram, JA; Barbers, RG; Equils, O; Mardekian, J; McLaughlin, JM; Schlamm, HT; Somerville, KT; Welch, VL | 1 |
| Brown, M; O'Reilly Zwald, F | 1 |
1 review(s) available for voriconazole and Carcinoma, Basal Cell
| Article | Year |
|---|---|
Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.
Topics: Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Education, Medical, Continuing; Female; Humans; Immunocompromised Host; Incidence; Male; Melanoma; Organ Transplantation; Prognosis; Pyrimidines; Risk Assessment; Sarcoma, Kaposi; Sirolimus; Skin Neoplasms; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2011 |
4 other study(ies) available for voriconazole and Carcinoma, Basal Cell
| Article | Year |
|---|---|
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
Topics: Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Incidence; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Skin Neoplasms; Triazoles; United States; Voriconazole | 2020 |
Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation.
Topics: Adult; Age Factors; Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Risk Factors; Sex Factors; Skin Neoplasms; Transplantation, Autologous; Transplantation, Homologous; Voriconazole | 2017 |
Risk Factors and Outcomes of Nonmelanoma Skin Cancer in Children and Young Adults.
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Case-Control Studies; Child; Child, Preschool; Female; Genetic Predisposition to Disease; Humans; Immunosuppressive Agents; Infant; Male; Radiotherapy; Retrospective Studies; Risk Factors; Skin Neoplasms; United States; Voriconazole; Young Adult | 2019 |
Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Heart Transplantation; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Proportional Hazards Models; Pyrimidines; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole; Young Adult | 2013 |